Drug intelligence / Profile preview

iCELL-SCI

Development stage
Preclinical
Lead developer
iCELL Biotechnology
Modality
Stem Cell Therapies → Cell Therapies
01

Overview

iCELL-SCI is an investigational cell therapy developed by iCELL Biotechnology for the treatment of spinal cord injury (SCI). The therapy utilizes Human Amniotic Epithelial Stem Cells (hAESCs), which are harvested from the amniotic membrane of the human placenta. These cells possess stem cell-like properties, including the ability to differentiate into multiple cell lineages and secrete various neurotrophic factors. hAESCs are characterized by low immunogenicity and significant immunomodulatory properties, making them suitable for allogeneic transplantation without the need for intensive immunosuppression. In the context of spinal cord injury, iCELL-SCI aims to promote neural repair, axonal regeneration, and functional recovery by modulating the local inflammatory microenvironment and providing neuroprotection. The program is currently in the preclinical stage of development.

Other names
Human Amniotic Epithelial Stem CellshAESC

Beyond the preview

Go deeper on iCELL-SCI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iCELL-SCI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call